Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13483)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 21, 2021 (publication date) through Jul 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chebli JMF, Queiroz NSF, Damião AOMC, Chebli LA, Costa MHM, Parra RS. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician. World J Gastroenterol 2021; 27(11): 1022-1042 [PMID: 33776370 DOI: 10.3748/wjg.v27.i11.1022] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i11/1022.htm |
| Number | Citing Articles |
| 1 |
Fatema Alrashed, Hajer Alasfour, Mohammad Shehab. Impact of biologics and small molecules for inflammatory bowel disease on COVID‐19‐related hospitalization and mortality: A systematic review and meta‐analysis. JGH Open 2022; 6(4): 241 doi: 10.1002/jgh3.12728
|
| 2 |
Niels Teich, Andreas Stallmach. COVID-19 und chronisch-entzündliche Darmerkrankungen. Die Gastroenterologie 2023; 18(2): 100 doi: 10.1007/s11377-023-00679-2
|
| 3 |
Jennifer B. Levin, Farren Briggs, Carol Blixen, Mark Bauer, Douglas Einstadter, Jeffrey M. Albert, Celeste Weise, Nicole Woods, Edna Fuentes-Casiano, Kristin A. Cassidy, Julie Rentsch, Kaylee Sarna, Martha Sajatovic. A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project. Trials 2022; 23(1) doi: 10.1186/s13063-022-06517-0
|
| 4 |
Yen-Ling Peng, Chung-Hsin Chang, Shu-Chen Wei, Tien-Yu Huang, Wei-Chen Tai, Wen-Hung Hsu, Deng-Chyang Wu, Hsu-Heng Yen, Chi-Ming Tai, Chen-Wang Chang, Wei-Chen Lin, Horng-Yuan Wang, Chun-Chi Lin, Chia-Jung Kuo, Cheng-Tang Chiu, Ching-Pin Lin, Hsi-Chang Lee, Jia-Feng Wu, Chen-Shuan Chung. Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study. Journal of the Formosan Medical Association 2023; 122(10): 1042 doi: 10.1016/j.jfma.2023.03.017
|
| 5 |
Fatima Hakak, Rajan N. Patel, Richard B. Gearry. Review article: Telecare in gastroenterology—Within the COVID‐19 pandemic and beyond. Alimentary Pharmacology & Therapeutics 2024; 59(10): 1170 doi: 10.1111/apt.17956
|
| 6 |
|
| 7 |
K. A. Dvornikova, E. Yu. Bystrova, L. P. Churilov, A. Lerner. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection. Molecular Biology Reports 2021; 48(7): 5745 doi: 10.1007/s11033-021-06565-w
|
| 8 |
Hemant Borase, Bhavana Mohite, Satish Patil, Jemisha Mistry, Mitesh Kumar Dwivedi, Ramar Krishnamurthy. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. 2022; : 271 doi: 10.1007/978-981-19-4800-8_14
|
| 9 |
Aaron Lerner, Carina Benzvi. Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination. 2023; : 451 doi: 10.1016/B978-0-443-18566-3.00009-8
|
| 10 |
Blake O. Langley, Sara E. Guedry, Joshua Z. Goldenberg, Douglas A. Hanes, Jennifer A. Beardsley, Jennifer Joan Ryan. Inflammatory Bowel Disease and Neutrophil–Lymphocyte Ratio: A Systematic Scoping Review. Journal of Clinical Medicine 2021; 10(18): 4219 doi: 10.3390/jcm10184219
|
| 11 |
Andreas Stallmach, Philipp A. Reuken, Philip Grunert, Niels Teich. Chronisch-entzündliche Darmerkrankungen in der COVID-Pandemie: Manifestationen und Management. Zeitschrift für Gastroenterologie 2022; 60(12): 1795 doi: 10.1055/a-1744-6697
|
| 12 |
Ahmad Hormati, Alireza Arezoumand, Hadi Dokhanchi, Mehdi Pezeshgi Modarres, Sajjad Ahmadpour. Inflammatory Bowel Disease Management during the COVID-19 Pandemic: A Literature Review. Middle East Journal of Digestive Diseases 2022; 14(2): 155 doi: 10.34172/mejdd.2022.269
|
| 13 |
Nicholas Scalzo, Ryan C. Ungaro. Managing IBD in the COVID-19 era. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231176450
|
| 14 |
Shirley Cohen-Mekelburg, Autumn Valicevic, Lewei (Allison) Lin, Sameer D. Saini, Hyungjin Myra Kim, Megan A. Adams. Inflammatory Bowel Disease Hospitalizations Are Similar for Patients Receiving Televisit-Delivered Outpatient Care and Those Receiving Traditional In-Person Care. American Journal of Gastroenterology 2024; 119(8): 1555 doi: 10.14309/ajg.0000000000002703
|
| 15 |
Georgios Kokkotis, Giorgos Bamias. Past But Not Forgotten: Innate Factors Affect the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2025; doi: 10.1093/ibd/izaf105
|
| 16 |
Gurpreet Malhi, Gurjot Minhas, Jason Chambers, Maria Mikail, Reena Khanna, Aze Wilson. Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic. Journal of the Canadian Association of Gastroenterology 2022; 5(6): 271 doi: 10.1093/jcag/gwac020
|
| 17 |
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?. International Immunopharmacology 2023; 116: 109597 doi: 10.1016/j.intimp.2022.109597
|
| 18 |
Antonietta Gerarda Gravina, Raffaele Pellegrino, Tommaso Durante, Giovanna Palladino, Rossella D'Onofrio, Simone Mammone, Giusi Arboretto, Salvatore Auletta, Giuseppe Imperio, Andrea Ventura, Mario Romeo, Alessandro Federico. Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?. World Journal of Methodology 2023; 13(4): 194-209 doi: 10.5662/wjm.v13.i4.194
Abstract(725) |
Core Tip(1029) |
Full Article(HTML)(6004)
|
Full Article with Cover (PDF)-2721K(167)
|
Full Article (Word)-1111K(41)
|
Audio-600K(12)
|
Peer-Review Report-219K(118)
|
Answering Reviewers-69K(122)
|
Full Article (PDF)-2510K(234)
|
Full Article (XML)-259K(118)
|
Times Cited (5)
|
Total Visits (11878)
|
Open
|
| 19 |
Fei Chen, Zhiqing Dai, Chaofan Huang, Huiran Chen, Xinyi Wang, Xinya Li. Gastrointestinal Disease and COVID-19: A Review of Current Evidence. Digestive Diseases 2022; 40(4): 506 doi: 10.1159/000519412
|
| 20 |
Marcia Henriques de Magalhães Costa, Ligia Yukie Sassaki, Júlio Maria Fonseca Chebli. Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease. World Journal of Gastroenterology 2024; 30(24): 3022-3035 doi: 10.3748/wjg.v30.i24.3022
|
| 21 |
A. S. Nikitina, O. V. Zamahina. Causes of digestive symptoms in patients with COVID-19. Scientific Bulletin of the Omsk State Medical University 2023; 3(4): 14 doi: 10.61634/2782-3024-2023-12-14-25
|
| 22 |
Fabiana Gil Melgaço, Tamiris Azamor, Livia Melo Villar, Ana Paula Dinis Ano Bom, Juliana Gil Melgaço. Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case. Viruses 2021; 13(11): 2143 doi: 10.3390/v13112143
|
| 23 |
Gen Suzuki, Ryuichi Iwakiri, Eri Udagawa, Sindy Ma, Ryoko Takayama, Hiroshi Nishiura, Koshi Nakamura, Samuel P. Burns, Paul Michael D’Alessandro, Jovelle Fernandez. Computational Simulation Model to Predict Behavior Changes in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Analysis of Two Regional Japanese Populations. Journal of Clinical Medicine 2023; 12(3): 757 doi: 10.3390/jcm12030757
|
| 24 |
Xijing Huang, Yan Pan, Ya Liu, Zhou Zhou, Yinghui Zhang, Caiping Gao, Chong He. Clinical Utility of the Neutrophil-to-Bilirubin Ratio in the Detection of Disease Activity in Ulcerative Colitis. Journal of Inflammation Research 2023; : 2549 doi: 10.2147/JIR.S413644
|
| 25 |
Amosy Ephreim M’Koma. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina 2022; 58(5): 567 doi: 10.3390/medicina58050567
|
| 26 |
Yu Nishida, Shuhei Hosomi, Yumie Kobayashi, Rieko Nakata, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Fumio Tanaka, Yasuaki Nagami, Koichi Taira, Noriko Kamata, Yasuhiro Fujiwara. Impact of the COVID-19 Pandemic on the Lifestyle and Psychosocial Behavior of Patients with Inflammatory Bowel Diseases: A Narrative Review. Healthcare 2023; 11(19): 2642 doi: 10.3390/healthcare11192642
|
| 27 |
Stefan Schreiber, Shomron Ben-Horin, Rieke Alten, René Westhovens, Laurent Peyrin-Biroulet, Silvio Danese, Toshifumi Hibi, Ken Takeuchi, Fernando Magro, Yoorim An, Dong-Hyeon Kim, SangWook Yoon, Walter Reinisch. Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era. Advances in Therapy 2022; 39(6): 2342 doi: 10.1007/s12325-021-01990-6
|
| 28 |
Aleksandra Kubas, Ewa Malecka-Wojciesko. COVID-19 Vaccination in Inflammatory Bowel Disease (IBD). Journal of Clinical Medicine 2022; 11(9): 2676 doi: 10.3390/jcm11092676
|